Sphingolipid Biology of Inflammation and Immunity
$646,174ZIAFY2015DKNIH
National Institute Of Diabetes And Digestive And Kidney Diseases
Investigators
Linked publications & trials
Paper 33926208Paper 33301355Paper 33296739Paper 32722120Paper 32091396Paper 32029474Paper 31171507Paper 31147448Paper 30060257Paper 29693558Paper 29383825Paper 29079828Paper 28802842Paper 28100772Paper 27226645Paper 27059959Paper 26268607Paper 26053123Paper 25954148Paper 25831442Paper 25498971Paper 25253697Paper 24667638Paper 24090699Paper 24081141Paper 23904439Paper 23359503Paper 23148237Paper 22735358Paper 22606352Paper 22504650Paper 21642988Paper 21248243Paper 21173151Paper 20950672Paper 20407207Paper 20404103Paper 20097939Paper 19483717Paper 19204730Paper 19109558Paper 18787560Paper 18424450Paper 18199826Paper 17346996
Abstract
We are studying the mechanism by which sphingolipids regulate immunity and inflammation. Our focus has been on sphingosine-1-phosphate (S1P), a bioactive lipid enriched in the vascular and lymphatic systems, and the S1P receptors, found on immune cells and the endothelium. Essential roles for S1P and its receptors have been found for immune system development and homeostasis as well as for the regulation of immune responses and inflammation. We are studying the individual roles of the S1P receptors and the sphingolipid metabolic pathway in inflammation and immunity.
View original record on NIH RePORTER →